Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Change in Receivables (2019 - 2025)

Historic Change in Receivables for AVITA Medical (RCEL) over the last 7 years, with Q4 2025 value amounting to -$81000.0.

  • AVITA Medical's Change in Receivables rose 9456.01% to -$81000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $3.6 million, marking a year-over-year increase of 18764.78%. This contributed to the annual value of $3.6 million for FY2025, which is 18764.78% up from last year.
  • Per AVITA Medical's latest filing, its Change in Receivables stood at -$81000.0 for Q4 2025, which was up 9456.01% from $2.3 million recorded in Q3 2025.
  • In the past 5 years, AVITA Medical's Change in Receivables ranged from a high of $2.8 million in Q1 2021 and a low of -$3.3 million during Q3 2021
  • In the last 5 years, AVITA Medical's Change in Receivables had a median value of -$57000.0 in 2023 and averaged -$201222.2.
  • In the last 5 years, AVITA Medical's Change in Receivables surged by 109420.29% in 2021 and then tumbled by 448181.82% in 2024.
  • Over the past 5 years, AVITA Medical's Change in Receivables (Quarter) stood at -$3.3 million in 2021, then surged by 103.18% to $106000.0 in 2022, then crashed by 1702.83% to -$1.7 million in 2023, then rose by 12.36% to -$1.5 million in 2024, then soared by 94.56% to -$81000.0 in 2025.
  • Its last three reported values are -$81000.0 in Q4 2025, $2.3 million for Q3 2025, and $1.6 million during Q2 2025.